Yüklüyor......
Targeted Therapies in Non-Small Cell Lung Cancer—Beyond EGFR and ALK
Systemic therapy for non-small cell lung cancer (NSCLC) has undergone a dramatic paradigm shift over the past decade. Advances in our understanding of the underlying biology of NSCLC have revealed distinct molecular subtypes. A substantial proportion of NSCLC depends on oncogenic molecular aberratio...
Kaydedildi:
| Yayımlandı: | Cancers (Basel) |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4491691/ https://ncbi.nlm.nih.gov/pubmed/26018876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers7020816 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|